SCHEMBL24251754

SCHEMBL24251754

CC1(C)C(=O)Nc2cc(Cl)c(F)cc21

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PGR P06401 12/20 0.49
ATAD2 Q6PL18 1/20 0.45
PDK2 Q15119 1/20 0.43
PDK4 Q16654 1/20 0.43
MAOB P27338 2/20 0.42
PDE3B Q13370 2/20 0.39
PDE3A Q14432 2/20 0.39
NR3C1 P04150 1/20 0.38
NR3C2 P08235 1/20 0.38
AR P10275 1/20 0.38
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
AURKA O14965 1/20 0.36
AURKB Q96GD4 1/20 0.36
AKR1B1 P15121 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29388984 1.00 PGR (0.49) PGRATAD2PDK2PDK4MAOB
SCHEMBL24690661 0.85 PGR (0.53) PGRATAD2PDK2PDK4MAOB
SCHEMBL7825677 0.85 PGR (0.50) PGRATAD2PDK2PDK4PDE3B
SCHEMBL24690659 0.79 PGR (0.47) PGRATAD2PDK2PDK4MAOB
SCHEMBL15577414 0.79 ATAD2 (0.45) PGRATAD2PDK2PDK4PDE3B
SCHEMBL3524836 0.78 PGR (0.71) PGRPDE3BPDE3ANR3C1NR3C2
SCHEMBL26666484 0.77 PGR (0.47) PGR
SCHEMBL24690662 0.76 AKR1B1 (0.50) PGRATAD2PDK2PDK4MAOB
SCHEMBL16858573 0.75 PGR (0.46) PGRATAD2PDK2PDK4PDE3B
SCHEMBL15264189 0.74 IDO1 (0.63) AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115836064-A Triazine derivative with EGFR (epidermal growth factor receptor) inhibitory activity and preparation method and application thereof 上海和誉生物医药科技有限公司 2023-03-21 CN disclosed
WO-2022033455-A1 TRIAZINE DERIVATIVE HAVING EGFR INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF 上海和誉生物医药科技有限公司 2022-02-17 WO disclosed
WO-2022033455-A1 TRIAZINE DERIVATIVE HAVING EGFR INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF 上海和誉生物医药科技有限公司 2022-02-17 WO disclosed